Lefebvre, Patrick <br/><br/>
The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease.  [electronic resource] 

 -  Disease management : DM  Feb 2007 
 - 37-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1093-507X 
<br/><br/><label>Standard No.: </label>10.1089/dis.2006.626  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Comorbidity<br/>Cost Savings<br/>Disease Progression<br/>Epoetin Alfa<br/>Erythropoietin--economics<br/>Glomerular Filtration Rate<br/>Hematinics--economics<br/>Humans<br/>Kidney Failure, Chronic--economics<br/>Medicare<br/>Models, Economic<br/>Recombinant Proteins<br/>Renal Dialysis--economics<br/>Retrospective Studies<br/>Time Factors<br/>United States